Allianz Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,470
| Closed | -$282K | – | 1628 |
|
|
2022
Q2 | $282K | Sell |
20,470
-7,800
| -28% | -$107K | ﹤0.01% | 1742 |
|
|
2022
Q1 | $449K | Sell |
28,270
-9,862
| -26% | -$157K | ﹤0.01% | 1746 |
|
|
2021
Q4 | $841K | Sell |
38,132
-13,775
| -27% | -$304K | ﹤0.01% | 1650 |
|
|
2021
Q3 | $1.55M | Buy |
51,907
+275
| +0.5% | +$8.22K | ﹤0.01% | 1435 |
|
|
2021
Q2 | $2.29M | Sell |
51,632
-56,194
| -52% | -$2.49M | ﹤0.01% | 1261 |
|
|
2021
Q1 | $4.78M | Buy |
107,826
+23,449
| +28% | +$1.04M | ﹤0.01% | 1021 |
|
|
2020
Q4 | $4.63M | Sell |
84,377
-259
| -0.3% | -$14.2K | ﹤0.01% | 1050 |
|
|
2020
Q3 | $1.93M | Sell |
84,636
-8,487
| -9% | -$194K | ﹤0.01% | 1261 |
|
|
2020
Q2 | $1.95M | Buy |
93,123
+29,873
| +47% | +$625K | ﹤0.01% | 1265 |
|
|
2020
Q1 | $882K | Buy |
63,250
+11,462
| +22% | +$160K | ﹤0.01% | 1486 |
|
|
2019
Q4 | $1.18M | Sell |
51,788
-37,511
| -42% | -$853K | ﹤0.01% | 1654 |
|
|
2019
Q3 | $1.04M | Buy |
+89,299
| New | +$1.04M | ﹤0.01% | 1675 |
|